| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy | Hepatology | 1999 | 378 |
| 2 | A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020) | Pharmacoeconomics | 2020 | 227 |
| 3 | Pain outcomes in patients with advanced breast cancer and bone metastases | Cancer | 2013 | 129 |
| 4 | The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain | European Journal of Cancer Care | 2010 | 106 |
| 5 | A systematic review of treatment guidelines for metastatic colorectal cancer | Colorectal Disease | 2012 | 93 |
| 6 | Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire | Cancer | 2007 | 89 |
| 7 | An Evaluation of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data | Medical Care | 2015 | 85 |
| 8 | Trends in RA patients’ adherence to subcutaneous anti-TNF therapies and costs | Current Medical Research and Opinion | 2009 | 83 |
| 9 | Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF) | BMC Cancer | 2013 | 80 |
| 10 | Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States | Archives of Osteoporosis | 2017 | 79 |
| 11 | Cost‐Effectiveness ofLDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States | Clinical Cardiology | 2016 | 74 |
| 12 | Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care | American Journal of Hematology | 2012 | 70 |
| 13 | Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab | Cephalalgia | 2018 | 62 |
| 14 | Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study | Acta Oncológica | 2014 | 59 |
| 15 | Evaluating risk prediction models for adults with heart failure: A systematic literature review | PLoS ONE | 2020 | 59 |
| 16 | Association of anemia correction with health related quality of life in patients not on dialysis | Current Medical Research and Opinion | 2007 | 56 |
| 17 | Acute and chronic impact of cardiovascular events on health state utilities | BMC Health Services Research | 2015 | 51 |
| 18 | Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients | Nephrology Dialysis Transplantation | 2008 | 49 |
| 19 | Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid | Annals of Oncology | 2012 | 48 |
| 20 | Measuring Asthma Control Is the First Step to Patient Management: A Literature Review | Journal of Asthma | 2009 | 45 |
| 21 | Healthcare costs in patients with metastatic lung cancer receiving chemotherapy | BMC Health Services Research | 2011 | 44 |
| 22 | Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study | Osteoporosis International | 2013 | 44 |
| 23 | Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective – prospective observational study – a cohort from 4 European countries | Journal of Bone Oncology | 2014 | 42 |
| 24 | Symptoms and markers of symptom severity in asthma—content validity of the asthma symptom diary | Health and Quality of Life Outcomes | 2015 | 39 |
| 25 | Psychometric Properties of the Osteoporosis-Specific Morisky Medication Adherence Scale in Postmenopausal Women with Osteoporosis Newly Treated with Bisphosphonates | Annals of Pharmacotherapy | 2012 | 38 |
| 26 | Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective | Journal of Medical Economics | 2016 | 38 |
| 27 | Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective | Journal of Medical Economics | 2018 | 38 |
| 28 | Health Care Use and Costs Associated With Use of a Health Club Membership Benefit in Older Adults with Diabetes | Diabetes Care | 2008 | 36 |
| 29 | Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity | Journal of Dermatological Treatment | 2013 | 36 |
| 30 | Causes and consequences of inflammation on anemia management in hemodialysis patients | Hemodialysis International | 2009 | 34 |
| 31 | International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries | ESMO Open | 2016 | 34 |
| 32 | Assessing Analgesic Use in Patients with Advanced Cancer: Development of a New Scale-The Analgesic Quantification Algorithm | Pain Medicine | 2014 | 33 |
| 33 | Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors | Vascular Health and Risk Management | 2018 | 31 |
| 34 | Patient Preferences for Preventive Migraine Treatments: A Discrete‐Choice Experiment | Headache | 2019 | 31 |
| 35 | Dosing patterns and costs of tumor necrosis factor inhibitor use for rheumatoid arthritis | American Journal of Health-System Pharmacy | 2010 | 30 |
| 36 | Estimating Effectiveness and Cost of Biologics for Rheumatoid Arthritis: Application of a Validated Algorithm to Commercial Insurance Claims | Clinical Therapeutics | 2014 | 29 |
| 37 | Cinacalcet Lowers Serum Alkaline Phosphatase in Maintenance Hemodialysis Patients | Clinical Journal of the American Society of Nephrology: CJASN | 2009 | 28 |
| 38 | A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer | British Journal of Cancer | 2011 | 27 |
| 39 | Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population | Journal of Managed Care & Specialty Pharmacy | 2015 | 27 |
| 40 | Longitudinal patterns of bone-targeted agent use among patients with solid tumors and bone metastases in the United States | Supportive Care in Cancer | 2017 | 26 |
| 41 | Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis | Osteoporosis International | 2018 | 26 |
| 42 | Health State Utilities of Patients with Heart Failure: A Systematic Literature Review | Pharmacoeconomics | 2021 | 26 |
| 43 | Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates | Quality of Life Research | 2014 | 25 |
| 44 | Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review | Pharmacoeconomics | 2019 | 25 |
| 45 | Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting | Journal of Rheumatology | 2018 | 24 |
| 46 | Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: Results of a survey of 985 patients | Clinical Therapeutics | 2008 | 23 |
| 47 | Manipulative Therapy and Rehabilitation for Recurrent Ankle Sprain With Functional Instability: A Short-Term, Assessor-Blind, Parallel-Group Randomized Trial | Journal of Manipulative and Physiological Therapeutics | 2015 | 23 |
| 48 | Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland | Applied Health Economics and Health Policy | 2013 | 22 |
| 49 | Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective | Journal of Medical Economics | 2017 | 22 |
| 50 | Treatment Patterns Following Discontinuation of Adalimumab, Etanercept, and Infliximab in a US Managed Care Sample | Advances in Therapy | 2014 | 21 |
